Over half of worldwide consumers (51%) want AI to improve their experience by helping them find products faster, according to February data from Twilio.
The world's top companies rely on EMARKETER for today's industry news and data validation to make big picture strategy decisions.
Become a ClientIn this podcast episode, we discuss the importance of physical touchpoints for brands and explore what attracts younger generations to in-store shopping experiences. We also examine the expectations consumers have for engaging in person experiences. Join our conversation with Senior Director of Podcasts and host, Marcus Johnson, Chief Client Strategy & Integration; President of Quad Agency Services, Tim Maleeny, and Vice President of Content, Suzy Davidkhanian. Listen everywhere you find podcasts and watch on YouTube and Spotify.
The insight: Amazon’s decision to double the length of its Prime Day sale delivered significant rewards for its advertising business—as we said it would. The takeaway: The first four-day Prime Day was an important learning experience for brands. With the event unlikely to get any shorter, sellers will need to be more precise about their ad strategy—focusing spending on times of day when shoppers are more likely to buy, or saving the bulk of their budgets for end-of-sale urgency.
The news: Bank of America notched a record second quarter for revenues, per Bloomberg. Revenues totaled $26.61 billion, lower than analysts’ anticipated $26.72 billion. Our take: Bank of America’s tight underwriting standards—its average credit cardholder FICO score is 777—have created a strong stable of superprime cardholders to drive volume through tempting rewards offerings.
The news: Cash App rolled out an extra layer of protection for minors’ P2P payments, with automatic flagging for sponsors (parents or guardians) to approve risky requests. Our take: Attracting young users at the beginning of their financial lives can yield long-term loyalty to the app.
The news: US retail sales rose 0.6% MoM in June, per the Commerce Department, well ahead of the projected 0.1% increase. On a YoY basis, sales were up a healthy 3.9%, a sign of consumers’ resilience in the face of considerable uncertainty. Our take: June’s upbeat sales report underscores the volatility of the current retail landscape. While consumers may currently feel secure enough to manage rising prices, that could quickly change as tariff-related cost increases begin to hit more directly.
The news: Mastercard launched the World Legend Mastercard, a premium card for higher-spending customers, alongside an overhaul of rewards and perks across the entire Mastercard Collection. Our take: We anticipate that card networks will jockey for the most premium cards as issuers cater to wealthy consumers’ reward wish lists.
The news: Circle K owner Alimentation Couche-Tard has dropped its bid to buy Japan’s Seven & i Holdings, casting doubt on whether the 7-Eleven operator’s planned US IPO will proceed, Bloomberg reported. Our take: As 7-Eleven continues efforts to strengthen its core business, the failed takeover bid offers lessons for retailers and brands. Decisions involving globally recognized brands should be strategic, not reactive. Retailers must maintain flexibility to revisit IPO or spin-off plans as business circumstances change.
The news: Pfizer and Bristol Myers Squibb will launch a direct-to-patient channel to sell their blockbuster blood thinner Eliquis at a reduced cash-pay price. Our take: Pfizer and Bristol Myers Squibb have anticipated the Eliquis patent loss and sales drop for years as part of the typical branded drug cycle. We see the new direct sales platform launch not as a play for new revenues, but rather a negotiating nod to the Trump administration. Only 10% of Eliquis patients are uncovered by insurance, so it’s a small market to court as a revenue-driving ploy. However, Trump has made it clear he’s open to using any levers possible to force lower drug prices, pushing pharma companies to offer good faith options and concessions.
The news:. A new report reviewed by STAT reveals that Pfizer and Eli Lilly pay their telehealth provider partners upwards of a few million dollars. Our take: Drugmakers in the D2C telehealth market likely won’t be too worried about the report’s findings. It will be difficult for regulators to prove that a pharma company’s payment to a telehealth partner is directly tied to prescription volume. Drug brands will need to boost awareness of their D2C offerings to justify the price they pay telehealth firms, however.
One Liberty Plaza9th FloorNew York, NY 100061-800-405-0844
1-800-405-0844sales@emarketer.com